Bio-FD&C Co., Ltd. engages in the development of bio and health technologies. Its products include vegetable cells, peptides, biomolecule, natural extract, and others. The company was founded on November 11, 2005 and is headquartered in Incheon, South Korea.

InSphero AG develops organotypic biological 3D microtissues and microtissue-based assays for biochemical compounds screening and predictive drug testing applications. It offers human prostate and mammary carcinoma, and rat liver microtissues. The company also provides compound toxicity testing, cell-invasion assays, stem-cell research, cell-to-cell interaction, regenerative medicine, tissue engineering, and cell-to-extracellular matrix interaction services. In addition, it involves in study of transcriptomics, proteomics, and metabolomics. Further, the company provides custom development services, which include microtissue development, H and E stained paraffin sections, growth characteristics data, and morphometric data. Its microtissue system enables the generation of various model systems using either tumor-derived cells to reconstitute primary tumors or primary cells to mimic structure and function of diverse organ tissues. InSphero AG was founded in 2009 and is based in Zurich, Switzerland.

Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. In 2018, the company's largest selling product lines were Neulasta, an immunostimulator used to prevent infections in patients undergoing cancer chemotherapy and Enbrel, a tumor necrosis factor blocker used in the treatment of rheumatoid arthritis and other autoimmune diseases. Other products include Epogen, Aranesp, Sensipar/Mimpara, Nplate, Vectibix, Prolia and XGEVA.

Ramsol Energy Llp is a private company headquartered in India. The firm operates as HR and recruiting company.

Guangzhou Saliai Stemcell Science & Technology Co., Ltd. engages in the provision of stem cell storage, health supplements, biological products, and related health management services. It involves in the production of regenerative medicine devices, medical nutrition supplements, and biological & medical cosmetic products. It operates a research and development platform which includes life bank, health management center, medical center, and medical cell center. The company was founded by Hai Jia Chen and Ming Jia Chen on July 7, 2009 and is headquartered in Guangzhou, China.

The Research Authority serves as the administrative and financial framework for research activities, scientific experiments and technical analyses carried out by Technion faculty, and TRDF staff. The missions of the Research & Development Division are: - Location, collection, processing and distribution of information concerning local and international research funding - Assistance in locating appropriate funding sources for Technion researchers - R&D information management services and in-campus marketing - Guidance and administrative services for Technion researchers in submitting research proposals to granting agencies and business entities - Management of contractual engagements with granting agencies and business entities - Contractual and budgetary administration of research grants and other accounts

Baxalta GmbH, a subsidiary of Takeda Pharmaceutical Co., Ltd., is a Swiss company located in Glattpark that manufactures and wholesales pharmaceutical products. It was founded in 2000. Julie So-Young Kim is currently the CEO of the firm.

Nanjing New Nordan Biotechnology Co., Ltd., established on 2012-10-26, Business scope includes biomedical technology research and development,technical consulting,technology transfer,Technical Services;R&D of instrumentation,Sales and technical service;R&D and sales of experimental consumables and reagents;Self-operated and agent import and export business of various commodities and technologies(Except where the state restricts enterprises to operate or prohibits the import and export of commodities and technologies).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Baxalta, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes treatments for hemophilia, bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, burns, and shock. The company was founded on March 13, 2015 and is headquartered in Chicago, IL.

Part of MOH Holdings Pte Ltd., Singapore Health Services Pte Ltd. is a Singaporean company located in Singapore. The firm provides medical services. Ivy Ng is the CEO, in this role since 2012.

Takeda Pharmaceutical Company Ltd (武田薬品工業株式会社 Takeda Yakuhin Kōgyō Kabushiki-gaisha) is the largest pharmaceutical company in Asia and one of the top 20 largest pharmaceutical companies in the world by revenue (top 10 following merger with Shire). The company has over 30,000 employees worldwide and achieved 16.2 billion USD in revenue during the 2012 fiscal year. The company is focused on metabolic disorders, gastroenterology, neurology, inflammation, as well as oncology through its independent subsidiary, Takeda Oncology. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States.

Baishijia (Shanghai) Medical Technology Co., Ltd. is a private company headquartered in China. The firm provides fetal cell prenatal diagnosis prediction and gene sequencing analysis techniques services.

Baxter Healthcare SA engages in the development, production, and sale of healthcare systems and products. It also acquires and manages participations in pharmaceutical-chemical firms. The company was founded on December 7, 2000 and is headquartered in Glattpark, Switzerland.

Suzhou Nuopu Regenerative Medicine Co., Ltd., established on 2016-09-13, Business scope includes biotechnology,biomaterials,Medical Technology,computer technology,bioartificial tissue,3DTechnology research and development in the field of printing,Technical Consulting and Technical Services(Does not contain human stem cells,Development and application of genetic diagnosis and treatment technology);3DPrinting equipment research and development;Production of Medical Devices,Sales and Repair;Testing services in the field of medicine and biotechnology,testing service;Medical Devices and Accessories,Experimental analysis instrument,Wholesale of biological reagents,import and export,Commission agency and related supporting business.(Where qualifications are involved,By qualification,License to operate)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) licensed items:Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;Inspection and testing service(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Sales of Class I Medical Devices;Sales of Class II Medical Devices;Domestic trade agent;Production of Class I Medical Devices;Additive Manufacturing Equipment Manufacturing;3DPrint base material sales(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Chongqing Bales Biotechnology Co., Ltd., established on 2012-07-11, Business scope includes licensed projects:Import and export,Technology Import and Export,Class III medical device business(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Technology development in the field of biotechnology,technical consulting,technology transfer,Technical Services,Cell Culture Technology Development,Sales of experimental reagents,mouse serum,Biological experiment reagent,chemical reagent,laboratory apparatus,Electrical Equipment(car not included),General Machinery,Chemical raw materials and products(Free of Hazardous Chemicals),Biological product development,Sales of Class II Medical Devices,Sales of Class I Medical Devices(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Huaxiayuan (Shanghai) Stem Cell Technology Co., Ltd., established on 2018-05-09, Business scope includes engaging in stem cell technology,Technology development in the field of biotechnology,technology transfer,technical consulting,Technical Services,Sales of Medical Devices. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Hebo Huikang Biotechnology Wuxi Co., Ltd., established on 2013-04-01, Business scope includes biotechnology,Medical Technology,Technology development in the field of computer science and technology,technology transfer,technical consulting,Technical Services;Training Services(Does not include certification,Does not include nationally recognized vocational certificate training);one,Class II medical device(Items that do not require a permit)promotion of;Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that the state restricts enterprises to operate or prohibits import and export).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Guangdong Zhaotai Cell Biotechnology Co., Ltd., established on 2020-11-27, Business scope includes general items:Medical Research and Experimental Development;R&D and application of cell technology;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)